Cargando…
Mathematical Model of Clonal Evolution Proposes a Personalised Multi-Modal Therapy for High-Risk Neuroblastoma
SIMPLE SUMMARY: Neuroblastoma is a rare type of cancer that usually affects children. The high-risk patients’ expected survival rate is less than 50%. One reason is the lack of precision in the standard treatment protocol: a one-size-fits-all multi-modal therapy. The study presented in this paper wa...
Autores principales: | Italia, Matteo, Wertheim, Kenneth Y., Taschner-Mandl, Sabine, Walker, Dawn, Dercole, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093626/ https://www.ncbi.nlm.nih.gov/pubmed/37046647 http://dx.doi.org/10.3390/cancers15071986 |
Ejemplares similares
-
Neuroblastoma and the epigenome
por: Fetahu, Irfete S., et al.
Publicado: (2021) -
Genetic heterogeneity and clonal evolution in neuroblastoma
por: Mora, J, et al.
Publicado: (2001) -
Personalising Practice Using Preferences for Meditation Anchor Modality
por: Anderson, Thomas, et al.
Publicado: (2018) -
A calibrated model with a single‐generator simulating polysomnographically recorded periodic leg movements
por: Italia, Matteo, et al.
Publicado: (2022) -
Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies—A Validation Study
por: Rifatbegovic, Fikret, et al.
Publicado: (2015)